{
  "title": "MRNA Vaccines And Therapeutics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "mrna-vaccines-and-therapeutics-market",
  "industry": "Pharmaceuticals & Therapeutics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/mrna-vaccines-and-therapeutics-market",
  "scraped_at": "2026-09-17T17:43:17+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 5.17,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 11.88,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 18.08,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia-Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "High"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "What is the current value of the mRNA vaccines and therapeutics market?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The mRNA vaccines and therapeutics market size reached USD 5.17 billion in 2026 and is forecast to grow to USD 11.8 billion by 2031."
      }
    },
    {
      "@type": "Question",
      "name": "Which mRNA construct type is growing fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Circular mRNA leads growth with a projected 130.01% CAGR through 2031, thanks to its lower dose requirement and robust immune response profile."
      }
    },
    {
      "@type": "Question",
      "name": "Why is oncology attracting so much attention in mRNA pipelines?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Breakthrough results such as the 49% reduction in melanoma recurrence from mRNA-4157 plus pembrolizumab have validated the modality, lifting oncology to a 17.20% CAGR."
      }
    },
    {
      "@type": "Question",
      "name": "How are manufacturing innovations influencing market expansion?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Modular closed-system and continuous-flow plants cut validation timelines and reduce batch costs, enabling more countries to build local production and supporting global market growth."
      }
    },
    {
      "@type": "Question",
      "name": "Which region will grow fastest over the next five years?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific is expected to expand at a 18.71% CAGR owing to supportive regulation, state funding, and cost-efficient manufacturing models."
      }
    },
    {
      "@type": "Question",
      "name": "What are the main barriers facing new entrants?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The most significant hurdles are cold-chain logistics, complex regulatory compliance, and ongoing lipid-nanoparticle patent disputes that can delay freedom-to-operate decisions."
      }
    }
  ],
  "images": [
    "images/mrna-vaccines-and-therapeutics-market-size-image-1779386387620.png",
    "images/mrna-vaccines-and-therapeutics-market-1779375210137-major-players.png",
    "images/mrna-vaccines-and-therapeutics-market-MRNA-Vaccines-And-Therapeutics-Market-Market-Share-by-mRNA-Construct-Type-2025-1779370480362.png",
    "images/mrna-vaccines-and-therapeutics-market-MRNA-Vaccines-And-Therapeutics-Market-Market-Share-by-Delivery-System-2031-1779370887054.png",
    "images/mrna-vaccines-and-therapeutics-market-MRNA-Vaccines-And-Therapeutics-Market-CAGR--Growth-Rate-by-Region-2026---2031-1767005715566.png",
    "images/mrna-vaccines-and-therapeutics-market-competitive-landscape-1779374552070.png",
    "images/market-snapshot.png",
    "images/pdf3.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/mrna-vaccines-and-therapeutics-market-size-image-1779386387620.png"
  ],
  "sections_count": 11
}